Clinical trial
A Prospective, Multicentric, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.
NCT03290456 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicentric, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 20, 2019
- Completion date
- October 20, 2029
- Enrollment
- 146 (estimated)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.
granulomatosis with polyangitis